Zobrazeno 1 - 2
of 2
pro vyhledávání: '"Noritoshi Shirouzu"'
Autor:
Shunya Tanaka, Masahiro Ohgidani, Nobuhiro Hata, Shogo Inamine, Noriaki Sagata, Noritoshi Shirouzu, Nobutaka Mukae, Satoshi O. Suzuki, Hideomi Hamasaki, Ryusuke Hatae, Yuhei Sangatsuda, Yutaka Fujioka, Kosuke Takigawa, Yusuke Funakoshi, Toru Iwaki, Masako Hosoi, Koji Iihara, Masahiro Mizoguchi, Takahiro A. Kato
Publikováno v:
Frontiers in Immunology, Vol 12 (2021)
Targeting the unique glioma immune microenvironment is a promising approach in developing breakthrough immunotherapy treatments. However, recent advances in immunotherapy, including the development of immune checkpoint inhibitors, have not improved t
Externí odkaz:
https://doaj.org/article/b12d5139e5f54e41bfca54e07b75f532
Autor:
Kosuke Takigawa, Koji Iihara, Noritoshi Shirouzu, Masako Hosoi, Masahiro Ohgidani, Nobutaka Mukae, Takahiro A. Kato, Yuhei Sangatsuda, Satoshi O. Suzuki, Nobuhiro Hata, Masahiro Mizoguchi, Hideomi Hamasaki, Shogo Inamine, Yutaka Fujioka, Yusuke Funakoshi, Noriaki Sagata, Shunya Tanaka, Ryusuke Hatae, Toru Iwaki
Publikováno v:
Frontiers in Immunology
Frontiers in Immunology, Vol 12 (2021)
Frontiers in Immunology, Vol 12 (2021)
Targeting the unique glioma immune microenvironment is a promising approach in developing breakthrough immunotherapy treatments. However, recent advances in immunotherapy, including the development of immune checkpoint inhibitors, have not improved t
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::1fd07bf33032554aab11b4197aaf6a16
https://pubmed.ncbi.nlm.nih.gov/34267749
https://pubmed.ncbi.nlm.nih.gov/34267749